SEC Comment Letter 0000000000-23-012696 to Rezolute, Inc. (RZLT)
Rezolute, Inc.
Date: Nov. 20, 2023 · CIK: 0001509261 · Accession: 0000000000-23-012696
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275562
Letter
United States securities and exchange commission logo November 20, 2023 Nevan Elam Chief Executive Officer Rezolute, Inc. 275 Shoreline Drive, Suite 500 Redwood City, CA 94065 Re:Rezolute, Inc. Registration Statement on Form S-3 Filed November 14, 2023 File No. 333-275562 Dear Nevan Elam: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Anthony W. Epps
Show Raw Text
United States securities and exchange commission logo
November 20, 2023
Nevan Elam
Chief Executive Officer
Rezolute, Inc.
275 Shoreline Drive, Suite 500
Redwood City, CA 94065
Re:Rezolute, Inc.
Registration Statement on Form S-3
Filed November 14, 2023
File No. 333-275562
Dear Nevan Elam:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Anthony W. Epps